VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 5404 · 108th Congress

Fair Vaccine Price Act of 2004

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

No cosponsors.

Fair Vaccine Price Act of 2004 - Prohibits the sale of any vaccine intended to prevent or mitigate the effects of influenza or any biological terrorist agent at a price per dose of 150 percent or more of the baseline price if: (1) a declared shortage of the vaccine is in effect; or (2) the seller knows or has substantial reason to believe there will be a…

What it does: CRS summary · Introduced in House · Nov 19, 2004

Fair Vaccine Price Act of 2004 - Prohibits the sale of any vaccine intended to prevent or mitigate the effects of influenza or any biological terrorist agent at a price per dose of 150 percent or more of the baseline price if: (1) a declared shortage of the vaccine is in effect; or (2) the seller knows or has substantial reason to believe there will be a shortage within 60 days and such a shortage is declared within such time. Allows the Secretary of Health and Human Services to declare a shortage period.

Designates as a vaccine's baseline price the average price of the vaccine sold by the seller either during the preceding 60 days or 12 months before the effective date of the shortage declaration. Allows the Secretary to determine an appropriate baseline price of the vaccine if the seller did not sell the vaccine during either such period or if the difference in price is unrelated to the causes of the shortage. Requires the Secretary to determine an appropriate baseline price at the time of declaring a shortage.

Sets forth penalties for violations under this Act, including imprisonment and a fine.

Allows a person to commence a civil action to compel compliance with, or for damages for violations of, this Act.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Fair Vaccine Price Act of 2004

Latest action (Dec 1, 2004): Referred to the Subcommittee on Health.

Policy area: Commerce · Origin: House · Introduced: Nov 19, 2004

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.